Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 4
1995 2
1996 1
1997 2
1998 1
1999 3
2001 2
2003 3
2004 8
2005 5
2006 4
2007 6
2008 6
2009 6
2010 9
2011 3
2012 8
2013 7
2014 10
2015 7
2016 7
2017 7
2018 12
2019 10
2020 9
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
The making of bispecific antibodies.
Brinkmann U, Kontermann RE. Brinkmann U, et al. Among authors: kontermann re. MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307. MAbs. 2017. PMID: 28071970 Free PMC article. Review.
Bispecific antibodies.
Kontermann RE, Brinkmann U. Kontermann RE, et al. Drug Discov Today. 2015 Jul;20(7):838-47. doi: 10.1016/j.drudis.2015.02.008. Epub 2015 Feb 26. Drug Discov Today. 2015. PMID: 25728220 Free article. Review.
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach.
Fischer R, Kontermann RE, Pfizenmaier K. Fischer R, et al. Among authors: kontermann re. Front Cell Dev Biol. 2020 May 26;8:401. doi: 10.3389/fcell.2020.00401. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32528961 Free PMC article. Review.
TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes.
Fischer R, Sendetski M, Del Rivero T, Martinez GF, Bracchi-Ricard V, Swanson KA, Pruzinsky EK, Delguercio N, Rosalino MJ, Padutsch T, Kontermann RE, Pfizenmaier K, Bethea JR. Fischer R, et al. Among authors: kontermann re. Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):17045-17050. doi: 10.1073/pnas.1902091116. Epub 2019 Aug 7. Proc Natl Acad Sci U S A. 2019. PMID: 31391309 Free PMC article.
Half-life extended biotherapeutics.
Kontermann RE. Kontermann RE. Expert Opin Biol Ther. 2016 Jul;16(7):903-15. doi: 10.1517/14712598.2016.1165661. Epub 2016 Apr 18. Expert Opin Biol Ther. 2016. PMID: 26967759 Review.
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models.
Fabre M, Ferrer C, Domínguez-Hormaetxe S, Bockorny B, Murias L, Seifert O, Eisler SA, Kontermann RE, Pfizenmaier K, Lee SY, Vivanco MD, López-Casas PP, Perea S, Abbas M, Richter W, Simon L, Hidalgo M. Fabre M, et al. Among authors: kontermann re. Clin Cancer Res. 2020 Jul 1;26(13):3420-3430. doi: 10.1158/1078-0432.CCR-19-2238. Epub 2020 Mar 11. Clin Cancer Res. 2020. PMID: 32161121
Back-to-Germline (B2G) Procedure for Antibody Devolution.
Schrade A, Bujotzek A, Spick C, Wagner M, Goerl J, Wezler X, Georges G, Kontermann RE, Brinkmann U. Schrade A, et al. Among authors: kontermann re. Antibodies (Basel). 2019 Aug 26;8(3):45. doi: 10.3390/antib8030045. Antibodies (Basel). 2019. PMID: 31544851 Free PMC article.
136 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page